Physicians’ Perception of Drug Information Resources in the Emirate of Abu Dhabi-UAE

Abstract

Objectives: To determine physicians’ preferences for different drug information resources in the United Arab Emirates. Methods: A questionnaire survey to determine preferences for different drug information resources was created and sent electronically from April 1 to May 13, 2012. A total of 3463 licensed physicians were identified from a comprehensive list of healthcare professionals provided by the Health Authority-Abu Dhabi Licensing Department. A total of 431 started the survey but only 372 physicians completed it entirely. Key Findings: Continuing medical education (46%) was ranked as the most favored source of information, followed by drug information references (28%), diagnosis/patient information (20%), and lastly peer-to-peer interactions (7%). Online sources of drug information were preferable (74%) to hardcopy (26%). A comparison of different physicians’ qualifications (consultant, specialist, and general practitioner) and number of references utilized for a particular topic (up to 3 resources versus 3 references or more) showed that their differences were statistically significant (p-value = 0.000). The most utilized sources of drug information by physicians was the British National Formulary (BNF), followed by Package Inserts, UpToDate, Drugs in Pregnancy & Lactation, Physicians’ Desk Reference, and Micromedex. When asked which drug information resource they would like to have access to, the majority of physicians choose the BNF, followed by UpToDate, MD Consult, Drugs in Pregnancy & Lactation, Micromedex, and Drugs Facts & Comparisons. Physicians from Europe/USA/Australia spent less time utilizing drug information resources (p-value of 0.013) compared to other nationalities. Conclusion: Preferences for different drug information resources did not vary significantly even amongst a diverse group of expatriate physicians licensed to practice in the United Arab Emirates.

Share and Cite:

H. Gharibyar, Y. Sharif, K. Qawasme and S. Fahmy, "Physicians’ Perception of Drug Information Resources in the Emirate of Abu Dhabi-UAE," Pharmacology & Pharmacy, Vol. 4 No. 1, 2013, pp. 52-56. doi: 10.4236/pp.2013.41007.

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1] S. A. Osiobe, “Use of Information Resources by Health Professionals: A Review of the Literature,” Social Science & Medicine, Vol. 21, No. 9, 1985, pp. 965-973.
[2] A. Woodsworth and V. R. Neufield, “A Survey of Physician Self-Education Patterns in Toronto Part I Use of Libraries,” Canadian Library Journal, Vol. 29, 1972, pp. 38-44.
[3] C. Gaither, R. P. Bagoui, D. M. Kirking and F. J. Ascione, “Factors Related to Physicians’ Attitudes and Beliefs toward Drug Information Sources,” Drug Information Journal, Vol. 28, 1994, pp. 817-827. doi:10.1177/009286159402800318
[4] G. H. Smith, D. L. Sorby and L. J. Sharp, “Physicians’ Attitudes toward Drug Information Resources,” American Journal of Hospital Phar-macy, Vol. 32, 1975, pp. 19-25.
[5] H. Gharibyar and Y. Sharif, “Evaluation of Pharmaceutical Drug Information Brochures in the Emirate of Abu Dhabi (United Arab Emirates),” Journal of Pharmaceutical Health Services Research, Vol. 3, No. 1, 2012, pp. 57-62. doi:10.1111/j.1759-8893.2011.00071.x
[6] H. S. Abou-Auda, “Information-Seeking Behavior and Attitudes of Physicians toward Drug Information Resources and Services in Saudi Arabia: A Nationwide Survey,” Saudi Medical Journal, Vol. 29, No. 1, 2008, pp. 107-115.
[7] G. L. Oppenheim, S. H. Erickson and C. Ashworth, “The Family Physician’s Knowledge of the Cost of Prescribed Drugs,” Journal of Family Practice, Vol. 12, No. 6, 1981, pp. 1027-1030.
[8] M. J. Kupst, et al., “Evaluation of Methods to Improve Communication in the Physician-Patient Relationship,” American Journal of Orthopsychiatry, Vol. 45, No. 3, 1975, pp. 420-429.
[9] E. Hemminki, “Review of Literature on the Factors Affecting Drug Prescribing,” Social Science & Medicine, Vol. 9, No. 2, 1975, pp. 111-116.
[10] R. A. Floyd and R. Taketoma, “Serum Drug Level Utilization Review—A Clinical Pharmacy Service,” Drug Intelligence & Clinical Pharmacy, Vol. 13, 1968, 99-105.
[11] S. Henley, W. Tester and R. Knapp, “Dissemination of Drug Information,” Hospitals, Vol. 42, No. 12, 1968, pp. 99-105.
[12] World Health Organization and Global Health Observatory (GHO), “Male to Female Ratio of Physicians Density per 1000 Population, Latest Available Year,” 2012. http://www.who.int/gho/health_workforce/physicians_density_gender_text/en/index.html
[13] R. H. Wharrad, “The Global Distribution of Physicians and Nurses,” Journal of Advanced Nursing, Vol. 30, No. 1, 1999, pp. 109-130.
[14] How Healthcare Professionals Perceive Medical Informaiton, “Medical Information & Professional Networking HCP Survey,” UBM Medica Asia, 2012.
[15] J. P. Gettig, J. K. Jordan and A. H. Sheehan, “A Survey of Current Perceptions of Drug Information Practice and Training,” Hospital Pharmacy, Vol. 44, No. 4, 2009, pp. 325-331. doi:10.1310/hpj4404-325
[16] W. E. Smith, M. D. Ray and D. M. Shannon, “Physician’s Expectations of Pharmacists,” American Journal of Health—System Pharmacy, Vol. 59, No. 1, 2002, pp. 50-57.
[17] A. D. Wein-berg, L. Ullian and W. D. Richards, “Informed Advice-and Information-Seeking between Physicians,” Journal of Medical Education, Vol. 56, 1981, pp. 174-180.

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.